Notably, after using combination therapy targeting EGFR amplification, the patient achieved some clinical benefit.[96] Li et al. proposed a possible explanation, suggesting the importance of trunk clone evaluation and tumor heterogeneity. Here, EGFR is linked to neoplasm.